06/02/2025
đ¨ Check out the latest Beyond Clean UK & Ireland Expert Series⢠release from our Ultrasound Probe Expert⢠Ellie Wishart! This 3-page PDF resource is available for download here: https://educate.beyondclean.net/42KQl7I
"High-level disinfection needs to be successful on every probe, every time, to protect every patient from infection risk. In addition to the validation that occurs when a device is manufactured and then installed, automated disinfection systems often have in-build indicators that verify critical efficacy parameters after every cycle. These parameters include time, temperature, disinfectant dosage and concentration, all of which can affect microbiological efficacy. Chemical or biological indicators provide a secondary independent verification of the disinfection process, above and beyond the validation that occurs during performance qualification.
In some countries, such as Germany, there is a legal requirement for on-site validation of the final reprocessing step of semi-critical devices. The Robert Koch Insitut (RKI) reported that they were unable to identify any standards or guidelines that demonstrated successful validation of manual wipes in this context. RKI identified that sufficient mechanical force and application of disinfectant to all surfaces and geometries of a device could not be guaranteed with wipes, making validation not possible. The Dusseldorf area health authority then released a statement on the RKI clarification, stating that wipe disinfection of semi-critical medical devices is not acceptable.
âIt is also not yet apparent to us how this could be validated on site as part of the validation of the reprocessing process. Therefore, we currently do not consider the final wipe disinfection of semi-critical medical devices to be validatable.â
Verification of efficacy parameters helps give staff peace of mind that high-level disinfection is being performed reproducibly, every time. If the parameters are not met, the user will be notified and the probe will not be used. Without this in-built verification of efficacy parameters, how can you be sure that the next patient is protected from infection risk?" - Ellie Wishart